FdaApplication
NDA 216099
Identifiers
- fda_app_no: NDA216099
Properties
| Property | Value |
|---|---|
| applicant_name | HANDA THERAPEUTICS LLC |
| application_type | NDA |
| approval_date | 2023-12-05 |
Products (6)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PHYRAGO | DASATINIB | 100MG | TABLET;ORAL |
| PHYRAGO | DASATINIB | 70MG | TABLET;ORAL |
| PHYRAGO | DASATINIB | 20MG | TABLET;ORAL |
| PHYRAGO | DASATINIB | 50MG | TABLET;ORAL |
| PHYRAGO | DASATINIB | 140MG | TABLET;ORAL |
| PHYRAGO | DASATINIB | 80MG | TABLET;ORAL |
6 products